168 related articles for article (PubMed ID: 34267605)
1. Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant
Kim JJE; Kocsmár I; Buzás GM; Szirtes I; Rusz O; Diczházi C; Szijártó A; Hritz I; Schaff Z; Kiss A; Kocsmár É; Lotz G
Pathol Oncol Res; 2021; 27():1609863. PubMed ID: 34267605
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept.
Kocsmár É; Kocsmár I; Buzás GM; Szirtes I; Wacha J; Takáts A; Hritz I; Schaff Z; Rugge M; Fassan M; Kiss A; Lotz G
Helicobacter; 2020 Feb; 25(1):e12670. PubMed ID: 31701608
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis.
Arenas A; Serrano C; Quiñones L; Harris P; Sandoval M; Lavanderos M; Sepúlveda R; Maquilón S; Echeverría A; Ríos C; Fuentes-López E; Rojas L; Jorquera A; Pizarro M; Camargo MC; Riquelme A
Sci Rep; 2019 Dec; 9(1):20070. PubMed ID: 31882676
[TBL] [Abstract][Full Text] [Related]
4. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides.
Kocsmár É; Buzás GM; Szirtes I; Kocsmár I; Kramer Z; Szijártó A; Fadgyas-Freyler P; Szénás K; Rugge M; Fassan M; Kiss A; Schaff Z; Röst G; Lotz G
Nat Commun; 2021 Apr; 12(1):2255. PubMed ID: 33859206
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
Horie R; Handa O; Ando T; Ose T; Murakami T; Suzuki N; Sendo R; Imamoto E; Itoh Y
Helicobacter; 2020 Aug; 25(4):e12698. PubMed ID: 32368846
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication in Mexico with a levofloxacin-based scheme versus standard triple therapy: Results from an open-label, randomized, noninferiority phase iiib trial.
Ladrón-de-Guevara L; Bornstein-Quevedo L; González-Huezo S; Castañeda-Romero B; Costa FG; di Silvio-López M
Rev Gastroenterol Mex (Engl Ed); 2019; 84(3):274-283. PubMed ID: 30060902
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain.
Navarro-Jarabo JM; Fernández-Sánchez F; Fernández-Moreno N; Hervas-Molina AJ; Casado-Caballero F; Puente-Gutierrez JJ; Pallares-Manrique H; Rodríguez-Ramos C; Fernández-Gutierrez C; Pérez-Aisa A; Rivas-Ruiz F; Montiel Quezel-Guerraz N
Digestion; 2015; 92(2):78-82. PubMed ID: 26227669
[TBL] [Abstract][Full Text] [Related]
8. Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label study.
Yi DM; Yang TT; Chao SH; Li YX; Zhou YL; Zhang HH; Lan L; Zhang YW; Wang XM; Zhang YR; Li J; Ding SZ
Medicine (Baltimore); 2019 Feb; 98(6):e14408. PubMed ID: 30732192
[TBL] [Abstract][Full Text] [Related]
9. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?
Kutluk G; Tutar E; Bayrak A; Volkan B; Akyon Y; Celikel C; Ertem D
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1202-8. PubMed ID: 25171023
[TBL] [Abstract][Full Text] [Related]
10. Genotypic determination of resistance and heteroresistance to clarithromycin in Helicobacter pylori isolates from antrum and corpus of Colombian symptomatic patients.
Arévalo-Jaimes BV; Rojas-Rengifo DF; Jaramillo CA; de Molano BM; Vera-Chamorro JF; Del Pilar Delgado M
BMC Infect Dis; 2019 Jun; 19(1):546. PubMed ID: 31226948
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single-center prospective pilot study.
Kwon YH; Jeon SW; Nam SY; Lee HS; Park JH
Helicobacter; 2019 Aug; 24(4):e12585. PubMed ID: 30969459
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children.
Feydt-Schmidt A; Rüssmann H; Lehn N; Fischer A; Antoni I; Störk D; Koletzko S
Aliment Pharmacol Ther; 2002 Dec; 16(12):2073-9. PubMed ID: 12452940
[TBL] [Abstract][Full Text] [Related]
13. Droplet Digital PCR-Based Detection of Clarithromycin Resistance in Helicobacter pylori Isolates Reveals Frequent Heteroresistance.
Sun L; Talarico S; Yao L; He L; Self S; You Y; Zhang H; Zhang Y; Guo Y; Liu G; Salama NR; Zhang J
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29925646
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori eradication rates in children upon susceptibility testing based on noninvasive stool polymerase chain reaction versus gastric tissue culture.
Vécsei A; Innerhofer A; Graf U; Binder C; Giczi H; Hammer K; Bruckdorfer A; Hirschl AM; Makristathis A
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):65-70. PubMed ID: 21694538
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
Osaki T; Mabe K; Zaman C; Yonezawa H; Okuda M; Amagai K; Fujieda S; Goto M; Shibata W; Kato M; Kamiya S
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28544222
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
Liu Q; Qi D; Kang J; Jin Y; Liu W; Gao W; Hou P; Lu J
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):221-5. PubMed ID: 25629566
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study.
Monno R; Giorgio F; Carmine P; Soleo L; Cinquepalmi V; Ierardi E
APMIS; 2012 Sep; 120(9):712-7. PubMed ID: 22882260
[TBL] [Abstract][Full Text] [Related]
19. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
20. Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens.
Muñoz-Gómez P; Jordán-Castro JA; Abanades-Tercero M; Blanco-González JJ; Andrés Esteban EM; Valle-Muñoz J
Helicobacter; 2018 Feb; 23(1):. PubMed ID: 29178562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
